Mammalian Cell Culture

  • Simon P. Langdon
Part of the Springer Protocols Handbooks book series (SPH)

1. Introduction

Mammalian cell culture is used widely in academic, medical and industrial settings. It has provided a means to study the physiology and biochemistry of the cell and developments in the fields of cell and molecular biology have required the use of reproducible model systems that only cultured cell lines can provide. For medical use, cell culture provides test systems to assess the efficacy and toxicology of potential new drugs. Large-scale mammalian cell culture has allowed production of biologically active proteins, initially production of vaccines and then recombinant proteins and monoclonal antibodies; recent innovative uses of cell culture include tissue engineering to generate tissue substitutes. This chapter will briefly review these areas.

1.1. Developments in Mammalian Cell Culture

The origins of mammalian cell culture began with organ and tissue culture and extend back to 1885 when Wilhelm Roux demonstrated that the medullary plate of a chick embryo could be...


Chinese Hamster Ovary Cell Mammalian Cell Culture Colony Form Efficiency Extensive Research Effort Somatic Cell Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Harrison RG (1907) Observations on the living developing nerve fiber. Proc Soc Exp Biol Med 4:140–143Google Scholar
  2. 2.
    Earle WR, Schilling EL, Stark TH, Straus NP, Brown MF, Shelton E (1943) Production of malignancy in vitro I V. The mouse fibroblast cultures and changes seen in the living cells. J Natl Cancer Inst 4:165–212Google Scholar
  3. 3.
    Gey GO, Coffman WD, Kubicek MT (1952) Tissue culture studies of the pro-liferative capacity of cervical carcinoma and normal epithelium. Cancer Res 12:364–365Google Scholar
  4. 4.
    Masters JR (2002) HeLa cells 50 years on: the good, the bad and the ugly. Nature Rev 2:315–318CrossRefGoogle Scholar
  5. 5.
    Weaver VM, Fischer AH, Peterson OW, Bissel MJ (1996) The importance of the microenvironment in breast cancer progression: recapitulation of mammary tumorigenesis using a unique human mammary epithelial cell model and a three-dimensional culture assay. Biochem Cell Biol 74:833–851PubMedCrossRefGoogle Scholar
  6. 6.
    Weaver VM, Bissel MJ (1999) Functional culture models to study mechanisms governing apoptosis in normal and malignant mammary epithelial cells. J Mammary Gland Biol Neopl 4:193–201CrossRefGoogle Scholar
  7. 7.
    Eagle H (1955) Amino acid metabolism in mammalian cultures. Science 130:432–437CrossRefGoogle Scholar
  8. 8.
    Eagle H (1955) Nutrition needs of mammalian cells in culture. Science 122:501PubMedCrossRefGoogle Scholar
  9. 9.
    Dulbecco R, Freeman G (1959) Plaque formation by polyoma virus Virology 8:396–397PubMedCrossRefGoogle Scholar
  10. 10.
    Iscove NN, Guilbert LW, Weyman C (1980) Complete replacement of serum in primary culture of erythropoietin-dependent red cell precursors (CFU-E) by albumin, transferring, iron, unsaturated fatty acid, lecithin and cholesterol. Exp Cell Res 126:121–126PubMedCrossRefGoogle Scholar
  11. 11.
    Morgan JF, Morton HJ, Parker RC (1950) The nutrition of animal cells in tissue culture. Initial studies on a synthetic medium. Proc Soc Exp Biol Med 73:1–8PubMedGoogle Scholar
  12. 12.
    Parker RC (1957) Altered cell strains in continuous culture: a general survey. In: Whitelock O (ed) Special Publications of the New York Academy of Sciences: 5, NY Acad Sci., New York, pp 303–313Google Scholar
  13. 13.
    Waymouth C (1959) Proliferation of sublines of NCTC clone 929 (strain L0 mouse cells in a simple chemically defined medium (MB752/1). J Natl Cancer Inst 22:1003PubMedGoogle Scholar
  14. 14.
    Ham RG (1963) An improved nutrient solution for diploid Chinese hamster and human cell lines. Exp Cell Res 29:515–526PubMedCrossRefGoogle Scholar
  15. 15.
    Ham RG (1965) Clonal growth of mammalian cells in a chemically defined, synthetic medium. Proc Natl Acad Sci USA 53:288–293PubMedCrossRefGoogle Scholar
  16. 16.
    McCoy TA, Maxwell M, Kruse PF (1959) Amino acid requirements of the Novikoff hepatoma in vitro. Proc Soc Exp Biol Med 100:115–118PubMedGoogle Scholar
  17. 17.
    Moore GE, Gerner RE, Franklin HA (1967) Culture of normal human leukocytes. JAMA 199:519–524PubMedCrossRefGoogle Scholar
  18. 18.
    Barnes D, Sato G (1980) Serum-free culture: a unifying approach. Cell 22:649–655PubMedCrossRefGoogle Scholar
  19. 19.
    Barnes D, Sato G (1980) Methods for growth of cultured cells in serum-free medium. Anal Biochem 102:519–524CrossRefGoogle Scholar
  20. 20.
    Ham RG, McKeehan WL (1978) Development of improved media and culture conditions for clonal growth of normal diploid cells. In vitro 14:11–22PubMedCrossRefGoogle Scholar
  21. 21.
    Hayflick L, Moorhead PS (1961) The serial cultivation of human diploid cell strains. Exp Cell Res 25:585–621CrossRefGoogle Scholar
  22. 22.
    Nelson-Rees WA, Daniels DW, Flandermeyer RR (1981) Cross-contamination of cells in culture. Science 212:446–452PubMedCrossRefGoogle Scholar
  23. 23.
    Boyd MR, Paull KD (1995) Some practical considerations and applications of the National Cancer Institute In Vitro Drug Discovery Screen. Drug Development Research 34:91–109CrossRefGoogle Scholar
  24. 24.
    Dieterich C, Schandar M, Noll M, Johannes F, Brunner H, Graeve T, Rupp (2002) In vitro reconstructed human epithelia reveal contributions of Candida albicans EFG1 and CPH1 to adhesion and invasion. Microbiology 148:497–506PubMedGoogle Scholar
  25. 25.
    Lawrence S (2005) Biotech drug market steadily expands. Nature Biotechnol 23:1466CrossRefGoogle Scholar
  26. 26.
    Pavlou A, Belsy M (2005) The therapeutic antibody market to 2008. Eur J Pharm Biopharm 59:389–396PubMedCrossRefGoogle Scholar
  27. 27.
    Pavlou A, Reichert J (2004) Recombinant protein therapeutics – success rates, market trends and values to 2010. Nature Biotechnol 22:1513–1519CrossRefGoogle Scholar
  28. 28.
    Wurm FW (2004) Production of recombinant protein therapeutics in cultivated mammalian cells. Nature Biotech 22:1393–1398CrossRefGoogle Scholar
  29. 29.
    Walsh G (2006) Biopharmaceutical benchmarks 2006. Nature Biotechnol 24:769–776CrossRefGoogle Scholar
  30. 30.
    Walsh G (2003) Biopharmaceutical benchmarks 2003. Nature Biotechnol 21:865–870CrossRefGoogle Scholar
  31. 31.
    Ott MG, Schmidt M, Schwarzaelder K, Stein S, Siler U, Koehl U (2006) Correction of X-linked chronic granulomatous disease by gene therapy, augmented by inser-tional activation of MDS1-EVI1, PRDM16 or SETBP1. Nature Med 12:401–409PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press, a part of Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Simon P. Langdon
    • 1
  1. 1.Cancer Research CentreUniversity of EdinburghEdinburghUK

Personalised recommendations